Fortis Healthcare Management Guidance Tracker
8 forward-looking guidance items tracked across 2 quarters.
Margins
Q1 FY26FY26 consolidated EBITDA margin expansion of ~200bps YoYActive
Management reiterated guidance of 200bps margin improvement for the full year, despite a strong Q1.
Q1 FY26Diagnostics EBITDA margin of 22-23% for FY26TrackedAgilus expects full-year EBITDA margins in the 22-23% range on net revenue basis.
Q3 FY26Continued margin improvement trajectory for at least 2 yearsTrackedSupported by brownfield expansions in high-margin facilities like fMRI and operational leverage.
Expansion
Q1 FY26Addition of ~900 beds in FY26, ~50% operationalized this yearTracked
Includes brownfield expansions at Noida, Faridabad, FMRI, and Manesar; 250 beds at FMRI to be completed by year-end.
Q3 FY26Brownfield bed addition of ~400 beds in FY27TrackedMajor contribution from fMRI expansion (200+ beds) to be commissioned in phases starting April 2026.